13:01 : Bio-pharmaceutical developer Novavax ([[NVAX]] +4%) trades higher after ... -
Bio-pharmaceutical developer Novavax (NVAX +4%) trades higher after winning a $1.3M contract from the U.S. Department of Homeland Security to develop a virus-like particle vaccine countermeasure to protect against foot-and-mouth disease. ...